TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15617454

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Losartan 50 mg
Number of subjects: 61
Study: 11578996

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 9215439

Group type: EXPERIMENTAL
Intervention: Observational surveys
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quasi-experimental studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled experiments
Number of subjects: 0
Study: 8423750

Group type: EXPERIMENTAL
Intervention: Downhill walking at 90 m.min‐1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Downhill walking at 105 m.min‐1
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Downhill walking at -9% and -12% grades
Number of subjects: 10
Study: 3663426

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg or 120 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31627908

Group type: EXPERIMENTAL
Intervention: Expanded polytetrafluoroethylene and fluorinated ethylene propylene-covered stents
Number of subjects: 154

Group type: COMPARATOR
Intervention: Uncovered nitinol stents
Number of subjects: 154
Study: 30297544

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 142

Group type: COMPARATOR
Intervention: Percutaneous catheter drainage
Number of subjects: 142
Study: 27679583

Group type: EXPERIMENTAL
Intervention: Absent peripheral pulses (n = 2,218)
Number of subjects: 11120
Study: 25677122

Group type: EXPERIMENTAL
Intervention: Preoperative short-course radiotherapy (PRT) plus total mesorectal excision (TME)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Total mesorectal excision (TME) alone
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Preoperative short-course radiotherapy (PRT)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Age ≤ 75 years at follow-up
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Major LARS
Number of subjects: 242
Study: 23592128

Group type: EXPERIMENTAL
Intervention: TUDCA
Number of subjects: 23

Group type: COMPARATOR
Intervention: UDCA
Number of subjects: 23
Study: 21089162

Group type: EXPERIMENTAL
Intervention: Diagnostic X-rays
Number of subjects: 20
Study: 18298907

Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 26
Study: 16779748

Group type: EXPERIMENTAL
Intervention: Macrolide therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 12818983

Group type: EXPERIMENTAL
Intervention: Newly designed tube with a hemispherical bevel and 2.5 mm outer diameter tube exchanger (TE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional polyvinyl chloride tube with a standard bevel
Number of subjects: 0
Study: 10221363

Group type: EXPERIMENTAL
Intervention: Antidepressant treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized control trials (RCT), controlled case studies, and epidemiological studies
Number of subjects: 0
Study: 8659773

Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (25 mL lidocaine)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (25 mL lidocaine) combined with general anesthesia
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low thoracic epidural anesthesia (12 mL lidocaine)
Number of subjects: 32
Study: 2024848

Group type: EXPERIMENTAL
Intervention: Night sleep study (N)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Day sleep study (D)
Number of subjects: 35
Study: 6661471

Group type: EXPERIMENTAL
Intervention: Intravenous diazepam
Number of subjects: 2

Group type: COMPARATOR
Intervention: Blind placebo
Number of subjects: 2

Group type: COMPARATOR
Intervention: Amyobarbitol
Number of subjects: 2
Study: 31571128

Group type: EXPERIMENTAL
Intervention: Cinnarizine 20 mg and Dimenhydrinate 40 mg
Number of subjects: 306

Group type: COMPARATOR
Intervention: Betahistine Dihydrochloride 16 mg
Number of subjects: 306
Study: 30096345

Group type: EXPERIMENTAL
Intervention: Small package size (350 g)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Large package size (1000 g)
Number of subjects: 205
Study: 26951414

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Therapy for Insomnia (MBTI)
Number of subjects: 54

Group type: COMPARATOR
Intervention: self‐monitoring control (SM)
Number of subjects: 54
Study: 24411480

Group type: EXPERIMENTAL
Intervention: Mahjong
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 110

Group type: COMPARATOR
Intervention: Simple handicrafts (control)
Number of subjects: 110
Study: 21751769

Group type: EXPERIMENTAL
Intervention: Guided imagery treatment group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 31
Study: 20484773

Group type: EXPERIMENTAL
Intervention: Auditory cue group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no auditory cue)
Number of subjects: 0
Study: 18515515

Group type: EXPERIMENTAL
Intervention: Foley catheter plus low-dose oxytocin
Number of subjects: 200

Group type: COMPARATOR
Intervention: Foley catheter alone (control)
Number of subjects: 200
Study: 15471616

Group type: EXPERIMENTAL
Intervention: LPS-induced cytokine production during psychosocial stress (Trier social stress test)
Number of subjects: 21

Group type: COMPARATOR
Intervention: LPS-induced cytokine production
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fatigue scores and basal LPS-induced cytokine levels
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cortisol responses to stress
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Basal levels of stimulated pro-inflammatory IL-6
Number of subjects: 21
Study: 12234231

Group type: EXPERIMENTAL
Intervention: Continuous labor support by a specially trained nurse
Number of subjects: 6915

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6915
Study: 9660522

Group type: EXPERIMENTAL
Intervention: Barnidipine (20 mg)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 106
Study: 7655932

Group type: EXPERIMENTAL
Intervention: Nursing challenge intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Staff training
Number of subjects: 0
Study: 2570002

Group type: EXPERIMENTAL
Intervention: 8 mg acrivastine three times daily
Number of subjects: 83

Group type: COMPARATOR
Intervention: 60 mg terfenadine twice daily
Number of subjects: 83
Study: 4608708

Group type: EXPERIMENTAL
Intervention: Inactivated monovalent A/Hong Kong vaccine
Number of subjects: 507

Group type: EXPERIMENTAL
Intervention: Inactivated monovalent A/England vaccine
Number of subjects: 507

Group type: COMPARATOR
Intervention: Influenza B vaccine
Number of subjects: 507
Study: 29178558

Group type: EXPERIMENTAL
Intervention: Large number training group (10 dilation models, 9 effacement/consistency models)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Small number training group (4 dilation models, 3 effacement/consistency models)
Number of subjects: 91
Study: 26649424

Group type: EXPERIMENTAL
Intervention: Perineural dexmedetomidine (DexP)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (DexIV)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (no dexmedetomidine)
Number of subjects: 99
Study: 24903347

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 4321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4321
Study: 22959557

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride + epinephrine (Group 1, n = 26)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride + epinephrine (Group 2, n = 35)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 5% Tramadol (Group 3, n = 12)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Anxiety scores (correlation analysis)
Number of subjects: 70
Study: 20503732

Group type: EXPERIMENTAL
Intervention: KAATSU-walk training (K-walk)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 18809642

Group type: EXPERIMENTAL
Intervention: Preferred music listening
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 60
Study: 16628507

Group type: EXPERIMENTAL
Intervention: Computer-based rehabilitation program (daily training for three weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no computer training)
Number of subjects: 20
Study: 12587100

Group type: EXPERIMENTAL
Intervention: Most promising experimental treatments selected at first interim analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Efficient score as a test statistic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trial power considerations
Number of subjects: 0
Study: 11213099

Group type: EXPERIMENTAL
Intervention: Interferon alfa (IFN‐alpha)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Symptomatic treatment
Number of subjects: 90
Study: 9441099

Group type: EXPERIMENTAL
Intervention: STH treatment (streptomycin, thiacetazone, isoniazid)
Number of subjects: 90
Study: 7936231

Group type: EXPERIMENTAL
Intervention: Flunarizine (FNR)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 3555382

Group type: EXPERIMENTAL
Intervention: Plasma exchange (7 exchange transfusions and one plasmapheresis)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High dose intravenous gammaglobulins
Number of subjects: 20
Study: 2406323

Group type: EXPERIMENTAL
Intervention: Active treatment (standardized Alternaria extract)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1072558

Group type: EXPERIMENTAL
Intervention: Diazepam-fentanyl supplemented with Althesin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Thiemebumal-N2O-O2
Number of subjects: 100

Group type: COMPARATOR
Intervention: Althesin-N2O-O2
Number of subjects: 100
Study: 31138296

Group type: EXPERIMENTAL
Intervention: ChroPreg intervention plus standard care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 0
Study: 28951033

Group type: EXPERIMENTAL
Intervention: Dentin-like glass fiber posts (GFPs)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Rigid titanium posts (TPs)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 91
Study: 26375288

Group type: EXPERIMENTAL
Intervention: Active supplementation with selenium and coenzyme Q10
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 23362293

Group type: EXPERIMENTAL
Intervention: Cholera vaccine
Number of subjects: 66990

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66990
Study: 21480469

Group type: EXPERIMENTAL
Intervention: 12 Gy CNS irradiation
Number of subjects: 486

Group type: COMPARATOR
Intervention: 18 Gy CNS irradiation
Number of subjects: 486
Study: 19461534

Group type: EXPERIMENTAL
Intervention: Active recovery (cycle ergometer, 30‐40 W)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Cold water immersion (three periods of 5 min at 15 ± 1 degrees C)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Electromyostimulation (bisymmetric TENS current)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 13
Study: 16600647

Group type: EXPERIMENTAL
Intervention: formoterol 12microg via Turbuhaler
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: salmeterol 50microg via Diskus
Number of subjects: 20
Study: 15035962

Group type: EXPERIMENTAL
Intervention: Gains in balance
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Gains in peak VO2 and lower limb Fugl‐Meyer score
Number of subjects: 92
Study: 11473961

Group type: EXPERIMENTAL
Intervention: Continuous administration of GnRH agonist during the luteal phase (cL group)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Long protocol (L group)
Number of subjects: 319
Study: 9744590

Group type: EXPERIMENTAL
Intervention: Picolax
Number of subjects: 194

Group type: COMPARATOR
Intervention: Fleet Phospho‐soda
Number of subjects: 194
Study: 8118746

Group type: EXPERIMENTAL
Intervention: sCT 100 IU/6 times a week
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: sCT 200 IU/3 times a week
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo/6 times a week
Number of subjects: 54
Study: 3281057

Group type: EXPERIMENTAL
Intervention: RS‐86 (10 mg/d) plus glycopyrrolate (6 mg/d)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 30898129

Group type: EXPERIMENTAL
Intervention: Tele-PCMHI delivered by clinical staff in routine care settings
Number of subjects: 6

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6
Study: 29142966

Group type: EXPERIMENTAL
Intervention: Elemental Mg 30 mmol/d
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Elemental Mg 15 mmol/d
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 26651828

Group type: EXPERIMENTAL
Intervention: Exposure in vivo treatment (EXP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Graded activity treatment (GA)
Number of subjects: 62
Study: 22258209

Group type: EXPERIMENTAL
Intervention: Kiwifruit (3 kiwifruits per day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Antioxidant-rich diet
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 20946333

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of bevacizumab 1.25 mg/0.05 ml
Number of subjects: 12

Group type: COMPARATOR
Intervention: Untreated eyes (control)
Number of subjects: 12
Study: 18692170

Group type: EXPERIMENTAL
Intervention: methylphenidate/behavioural treatment (BT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: methylphenidate-only
Number of subjects: 90
Study: 16822823

Group type: EXPERIMENTAL
Intervention: Ragaglitazar
Number of subjects: 345
Study: 12588583

Group type: EXPERIMENTAL
Intervention: Walk + (home-based pedometer-driven walking program with arthritis self-management education)
Number of subjects: 34

Group type: COMPARATOR
Intervention: EDU (arthritis self-management education alone)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Walk +
Number of subjects: 34

Group type: COMPARATOR
Intervention: EDU
Number of subjects: 34
Study: 11090798

Group type: EXPERIMENTAL
Intervention: Quinapril (angiotensin-converting enzyme inhibitor)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8923865

Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I (IGF-I) 60 micrograms/kg
Number of subjects: 8
Study: 1482187

Group type: EXPERIMENTAL
Intervention: Uncooked vegan diet for 1 month
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional diet
Number of subjects: 18
Study: 3977582

Group type: EXPERIMENTAL
Intervention: Kegel's exercises (vaginal musculature contractions)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Kegel's exercises with self-generated fantasy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Kegel's exercises (after 1 week of practice)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Informed about Kegel's exercises but did not practice
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no information about Kegel's exercises)
Number of subjects: 30
Study: 30676012

Group type: EXPERIMENTAL
Intervention: Boswellia serrata lecithin-based delivery form (Casperome®) - one tablet/day
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard management (SM) group: diet and, if needed, hyoscine butylbromide (Buscopan®) or papaverine hydrochloride + 10 mg of Atropa belladonna extract
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard management (SM) group
Number of subjects: 69
Study: 29738346

Group type: EXPERIMENTAL
Intervention: Red meat group (56g/day of lean red meat added)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 27523046

Group type: EXPERIMENTAL
Intervention: SRP + LLLT
Number of subjects: 25

Group type: COMPARATOR
Intervention: SRP
Number of subjects: 25
Study: 24494593

Group type: EXPERIMENTAL
Intervention: Computer-assisted self-management
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Computer-assisted self-management plus problem-solving therapy
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Health education
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: All intervention groups
Number of subjects: 392
Study: 24246458

Group type: EXPERIMENTAL
Intervention: Kangaroo Care (KC)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Both KC and SC
Number of subjects: 38
Study: 20735289

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Immunomodulatory therapy (IMT)
Number of subjects: 16
Study: 19052246

Group type: EXPERIMENTAL
Intervention: Arm ergometer therapy (n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Robotic therapy (n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Occupational therapy (OT) group (control) (n = 10)
Number of subjects: 30
Study: 15705982

Group type: EXPERIMENTAL
Intervention: Statin drug therapy initiation protocol at hospital discharge
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Statin drug therapy initiation protocol
Number of subjects: 403

Group type: COMPARATOR
Intervention: Historical control group (no statin initiation protocol)
Number of subjects: 403
Study: 12907105

Group type: EXPERIMENTAL
Intervention: Lorazepam (1 mg) administered intravenously 1 hour after surgery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo administered intravenously 1 hour after surgery
Number of subjects: 90
Study: 10603730

Group type: EXPERIMENTAL
Intervention: 200 micrograms iodine/d
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: 500 micrograms iodine/d
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: 1.5 mg iodine/week
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: 150 micrograms iodine/d plus 75 to 100 micrograms T4/d
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: 100 micrograms iodine plus 100 micrograms T4/d
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Combined iodine/T4 treatment
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: Single-T4 therapy
Number of subjects: 262

Group type: COMPARATOR
Intervention: Healthy people
Number of subjects: 262

Group type: COMPARATOR
Intervention: Patients with goitre
Number of subjects: 262

Group type: COMPARATOR
Intervention: Patients with nodular goitres
Number of subjects: 262
Study: 7573726

Group type: EXPERIMENTAL
Intervention: Mitoxantrone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Melphalan
Number of subjects: 88
Study: 2045382

Group type: EXPERIMENTAL
Intervention: Repeated plasmapheresis prior to pulse cyclophosphamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pulse cyclophosphamide alone
Number of subjects: 0
Study: 7002482

Group type: COMPARATOR
Intervention: Tolmetin sodium (1600 mg daily)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Aloxiprin (initially 6 g daily, reduced to 4 g daily after 3 months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Phenylbutazone (400 mg daily)
Number of subjects: 46
Study: 31208778

Group type: EXPERIMENTAL
Intervention: SuperPath approach
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional posterior approach
Number of subjects: 100
Study: 27806023

Group type: EXPERIMENTAL
Intervention: Core depressive symptoms
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Sleep symptoms
Number of subjects: 267
Study: 25763792

Group type: EXPERIMENTAL
Intervention: Lifestyle Modification Program (LMP)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 104
Study: 23179365

Group type: EXPERIMENTAL
Intervention: LINE-1 hypomethylation
Number of subjects: 203
Study: 21545385

Group type: EXPERIMENTAL
Intervention: Exercise + HSGS
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Exercise only
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: HSGS only
Number of subjects: 147

Group type: COMPARATOR
Intervention: Education group
Number of subjects: 147
Study: 18613809

Group type: EXPERIMENTAL
Intervention: Disulfiram (≤ 250 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo or index groups
Number of subjects: 0
Study: 16792607

Group type: EXPERIMENTAL
Intervention: Needle-through-needle technique
Number of subjects: 116

Group type: COMPARATOR
Intervention: Double segment technique
Number of subjects: 116
Study: 12680734

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 28
Study: 10636129

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 462

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462
Study: 1384304

Group type: EXPERIMENTAL
Intervention: Almokalant 4.5 mg intravenously over 10 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3925972

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30967649

Group type: EXPERIMENTAL
Intervention: Intermittent letrozole
Number of subjects: 956

Group type: COMPARATOR
Intervention: Continuous letrozole
Number of subjects: 956
Study: 30232642

Group type: EXPERIMENTAL
Intervention: Pre-ovulatory follicular fluid (FF) levels of soluble urokinase plasminogen activator receptor (suPAR) in women with severe OHSS (n = 25)
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Pre-ovulatory follicular fluid (FF) levels of soluble urokinase plasminogen activator receptor (suPAR) in high-risk controls (n = 25)
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Pre-ovulatory follicular fluid (FF) levels of soluble urokinase plasminogen activator receptor (suPAR) in low-risk controls (n = 25)
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic curve analysis for suPAR levels predicting severe OHSS
Number of subjects: 1050
Study: 27902713

Group type: EXPERIMENTAL
Intervention: GlycA (N-acetyl glycan groups attached to acute phase proteins)
Number of subjects: 34320

Group type: EXPERIMENTAL
Intervention: GlycA
Number of subjects: 34320

Group type: COMPARATOR
Intervention: hsCRP, fibrinogen, and sICAM-1
Number of subjects: 34320